Tryptamine → 2,3,4,9-Tetrahydro-1-(4-methylphenyl)-1H-pyrido[3,4-b]indole

HRID 1637871Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1637871
[NH2:1][CH2:2][CH2:3][C:4]1[C:12]2[C:7](=[CH:8][CH:9]=[CH:10][CH:11]=2)[NH:6][CH:5]=1.[CH3:13][C:14]1[CH:21]=[CH:20][C:17]([CH:18]=O)=[CH:16][CH:15]=1.C(O)(C(F)(F)F)=O>>[CH3:13][C:14]1[CH:21]=[CH:20][C:17]([CH:18]2[C:5]3[NH:6][C:7]4[C:12](=[CH:11][CH:10]=[CH:9][CH:8]=4)[C:4]=3[CH2:3][CH2:2][NH:1]2)=[CH:16][CH:15]=1

Komponenten

4

Edukt 3

HCID 1150TryptamineHCID 6422Trifluoroacetic acidHCID 77254-Methylbenzaldehyde

Produkt 1

HCID 33525052,3,4,9-Tetrahydro-1-(4-methylphenyl)-1H-pyrido[3,4-b]indoleAusbeute 100 %

Versuchsvorschrift

This product was prepared using the same procedure as for Intermediate 1 with tryptamine (1.0 g, 6.2 mmol), 4-methylbenzaldehyde (0.74 g, 1 equiv.) and TFA (1 mL, 2 equiv.) to give the title compound (1.6 g, 100%) as a white powder. MP: 207-209° C.

Aufarbeitung

  1. customThis product was prepared

Quellen und Nachweise

ORD-Eintrag
ord-fef35e02808b45f1bfd9ec448876e2e8
Quelldatensatz
uspto-grants-2000_03
Patentnummer
US06043252

Notizen zur Reaktion

Wird geladen…